首页> 外文期刊>Seminars in dialysis >Should ultrapure dialysate be part of standard therapy in hemodialysis?
【24h】

Should ultrapure dialysate be part of standard therapy in hemodialysis?

机译:超纯透析液是否应成为血液透析标准治疗的一部分?

获取原文
获取原文并翻译 | 示例
           

摘要

Over the years, hemodialyzer membranes have gained in performance translating into major increases in both small and middle molecule clearances (high-flux membranes) and marked improvements in biocompatibility (synthetic high-flux membranes) (1). These membrane changes, as well as alterations in dialyzer geometric design, have resulted in an increase in back-transport (2) making the microbiological purity of dialysate a critical component in the hemodialysis biocompatibility network (3). Standards for the purity of water and dialysate established in the seventies were later recognized as inadequate for contemporary hemodialysis conditions (4). A recent transcontinental agreement (Europe, US, Japan) recognizes the necessity of upgrading water and dialysate quality for all dialysis modalities. For this purpose, guidelines supporting the regular use of ultrapure dialysis fluid (UPDF) for all hemodialysis modalities have been produced (5-7).
机译:多年来,血液透析膜的性能得到了提高,转化为中小分子清除率(高通量膜)的显着增加,并且生物相容性得到了显着改善(合成高通量膜)(1)。这些膜的变化以及透析器几何设计的改变,导致反向转运的增加(2),使透析液的微生物纯度成为血液透析生物相容性网络(3)的关键组成部分。七十年代建立的水和透析液纯度标准后来被认为不足以适应当前的血液透析条件(4)。最近的一项跨洲协议(欧洲,美国,日本)认识到所有透析方式都必须提高水和透析液的质量。为此目的,已经制定了支持在所有血液透析方式中定期使用超纯透析液(UPDF)的指南(5-7)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号